Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.15
+0.27 (4.59%)
At close: Mar 31, 2026, 4:00 PM EDT
6.03
-0.12 (-1.95%)
After-hours: Mar 31, 2026, 7:49 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $163.03 million as of March 31, 2026. Its market cap has decreased by -60.17% in one year.
Market Cap
163.03M
Enterprise Value
50.04M
1-Year Change
-60.17%
Ranking
Category
Stock Price
$6.15
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has decreased from $166.07M to $163.03M, a decrease of -1.83%. That is a compound annual growth rate of -0.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 155.87M | -16.86% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 163.20M |
| Sagimet Biosciences | 159.34M |
| Tiziana Life Sciences | 158.25M |
| Precision BioSciences | 155.34M |
| Corbus Pharmaceuticals Holdings | 154.48M |
| Molecular Partners AG | 152.41M |
| Humacyte | 150.00M |
| Korro Bio | 149.99M |